Characterization of Dendritic Cells and Macrophages Generated by Directed Differentiation from Mouse Induced Pluripotent Stem Cells

Methods have been established to generate dendritic cells (DCs) from mouse and human embryonic stem (ES) cells. We designated them as ES‐DCs and mouse models have demonstrated the induction of anti‐cancer immunity and prevention of autoimmune disease by in vivo administration of genetically engineer...

Full description

Saved in:
Bibliographic Details
Published inStem cells (Dayton, Ohio) Vol. 27; no. 5; pp. 1021 - 1031
Main Authors Senju, Satoru, Haruta, Miwa, Matsunaga, Yusuke, Fukushima, Satoshi, Ikeda, Tokunori, Takahashi, Kazutoshi, Okita, Keisuke, Yamanaka, Shinya, Nishimura, Yasuharu
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.05.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Methods have been established to generate dendritic cells (DCs) from mouse and human embryonic stem (ES) cells. We designated them as ES‐DCs and mouse models have demonstrated the induction of anti‐cancer immunity and prevention of autoimmune disease by in vivo administration of genetically engineered ES‐DCs. For the future clinical application of ES‐DCs, the histoincompatibility between patients to be treated and available human ES cells and the ethical concerns associated with human ES cells may be serious obstacles. However, recently developed induced pluripotent stem (iPS) cell technology is expected to resolve these issues. This report describes the generation and characterization of DCs derived from mouse iPS cells. The iPS cell‐derived DCs (iPS‐DCs) possessed the characteristics of DCs including the capacity of T‐cell‐stimulation, antigen‐processing and presentation and cytokine production. DNA microarray analyses revealed the upregulation of genes related to antigen‐presenting functions during differentiation into iPS‐DCs and similarity in gene expression profile in iPS‐DCs and bone marrow cell‐derived DCs. Genetically modified iPS‐DCs expressing antigenic protein primed T‐cells specific to the antigen in vivo and elicited efficient antigen‐specific anti‐tumor immunity. In addition, macrophages were generated from iPS cells (iPS‐MP). iPS‐MP were comparable with bone marrow cell‐derived macrophages in the cell surface phenotype, functions, and gene expression profiles. Stem Cells 2009;27:1021–1031
Bibliography:First published online in S
ells
February 13, 2009; available online without subscription through the open access option.
C
Express
Telephone: +81‐96‐373‐5313; Fax: +81‐96‐373‐5314
Author contributions: S.S.: conception and design, collection of data, manuscript writing, final approval of manuscript; M.H., Y.M., S.F., and T.I.: collection of data, final approval of manuscript; K.T., K.O., and S.Y.: provision of study material, final approval of manuscript; Y.N.: manuscript writing, final approval of manuscript.
tem
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1066-5099
1549-4918
DOI:10.1002/stem.33